Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and/or meta-analyses
Author(s) -
Margaret K. Doll,
Nicholas Winters,
Constantina Boikos,
Hannah KraicerMelamed,
Geneviève Gore,
Caroline Quach
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx271
Subject(s) - oseltamivir , zanamivir , medicine , neuraminidase inhibitor , odds ratio , population , vomiting , nausea , neuraminidase , regimen , pneumonia , randomized controlled trial , virology , virus , environmental health , disease , covid-19 , infectious disease (medical specialty)
To review evidence from systematic reviews and/or meta-analyses (SR/MAs) regarding neuraminidase inhibitor (NI) safety and effectiveness.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom